Story collaborations

Thank you to our generous community who shared their stories this year to help us raise vital funds for new GI cancer research.

Greg wearing a hospital gown and a blue surgical mask, giving a determined thumbs-up to the camera.
“When they asked me about joining the trial, I said, I have nothing to lose,” says Greg. “I meant that sincerely, because I had nothing to lose. Without the trial, I don’t believe I’d be alive today.”

Greg’s story

Greg thought of himself as healthy and active when he went in for a routine heart ablation in early 2023. A few days later, tests revealed a mass on his pancreas. The diagnosis was pancreatic cancer.

When his surgeon mentioned a clinical trial called NEO-IMPACT, Greg chose to take part, knowing it could offer an approach beyond standard treatment. Through the trial, Greg received treatment he would not otherwise have been able to access.

The chemotherapy was hard. Greg lost weight and developed neuropathy that persists today. Recovery from surgery was slow, and he had to learn his body's new limitations. But then came the scans with unexpected news: the cancer was completely gone.

“When they asked me about joining the trial, I said, I have nothing to lose,” says Greg. “I meant that sincerely, because I had nothing to lose. Without the trial, I don’t believe I’d be alive today.”
Karen sitting on a stone bench in a lush garden, wearing a white "No Guts No Glory" t-shirt.
“I have to do everything I can to help other people never go through what I’ve gone through.”

Karen’s story

Karen Humphries is on a mission. Driven by her experience with cholangiocarcinoma, Karen is a fierce patient advocate, determined to raise awareness and see improved survival outcomes for the disease. 

Throughout her journey, Karen has been resolute in shining a light on the disease. She’s channelled her determination into numerous public speaking engagements, media interviews – and this year, hosting a World Cholangiocarcinoma Day event.

“I’m here to make a change,” she says.

“I have to do everything I can to help other people never go through what I’ve gone through.”
A man named Lachie wearing a blue linen shirt, laughing and cheering as he walks through a doorway.
“He said, if sharing my story helps one other person, then it’s worth it,” Lachlan’s sister remembers.

Lachlan’s story

Lachlan was known for his cheeky humour and big heart. A devoted father to his young son Leo, he was only in his thirties when stomach pains led to a diagnosis of advanced bowel cancer.

Lachlan chose to be open about his experience, wanting others to understand what it was like to live with bowel cancer and why research mattered. His honesty broke through the silence that can surround cancer, especially for younger men.

Lachlan passed away in 2023, surrounded by those who loved him. To honour his memory and determination to make a difference, the Lachlan Kean Foundation was created, supporting bowel cancer research and awareness.

“He said, if sharing my story helps one other person, then it’s worth it,” Lachlan’s sister remembers.
Triangle behind a mountain range made with structural grid like texture
"I know that if Dad was here today, he would be backing me to do what I’m doing at every point. Stay strong for each other – you're not alone.”

Brooklynn and Jim’s story

Brooklynn, a medical technician in the Royal Australian Air Force and member of our Community Advisory Panel (CAP), graciously shared her family's journey with her father Jim's oesophageal cancer diagnosis.

Jim was a farmer in the Riverina, fit and healthy when he was diagnosed in July 2021. The news changed everything for their family.

Despite treatment including immunotherapy, chemotherapy, radiation and surgery, Jim never stopped showing up for his daughters. 

Jim passed away in November 2023. Joining the CAP has given Brooklynn purpose, using her clinical background and lived experience to review research materials and make them clearer for families like hers.

"I know that if Dad was here today, he would be backing me to do what I’m doing at every point. Stay strong for each other – you're not alone.”
Jodie and a companion leaning against a rustic wooden fence in a sunlit, green rural setting.
“You’d forget, and instinctively just go to grab something. Even going to drink a glass of tap water – the moment it touched my throat, it felt like everything just wanted to close up,” Jodie recalls.

Jodie’s story

For many people with colorectal cancer, chemotherapy can be lifesaving. However, a common treatment can lead to a side effect that causes people to feel pain, numbness or pins and needles in their body at a single touch. This is called chemotherapy-induced peripheral neuropathy, CIPN for short, and it can be one of the most difficult side effects a patient can experience.

While undergoing treatment for colorectal cancer, Jodie – Deputy Chair of the Community Advisory Panel – experienced neuropathy as a side effect, mainly in her hands and feet.

“You’d forget, and instinctively just go to grab something. Even going to drink a glass of tap water – the moment it touched my throat, it felt like everything just wanted to close up,” Jodie recalls.

Another incredible year of community fundraising making a real difference

Community fundraising plays a vital role in progressing new GI cancer research.

We are deeply grateful to our fundraisers and supporters for everything they contributed in 2025. Your generosity helps us continue to open new trials and give hope to people with GI cancer.

Every Gutsy Challenge and community event this year was a great success, and together we raised an incredible $220,500.

Here is a snapshot of our community and fundraising events in 2025.

Two women smiling while holding a large white laundry basket filled with raffle prizes in front of a Harcourts banner.

Jenny Horn

Ten years ago, Jenny Horn sadly lost her husband, Rusty, to liver cancer. In his honour, and with the support of her team at Harcourts Yeppoon, Jenny brought together more than 80 people for a special golf day, raising over $7,000 for GI cancer research.

Three men and a young boy smiling together in front of a golf cart on a sunny golf course.

John Paduano

Every February, John Paduano and Dave Munro bring the Mollymook community together to host the Alex and Adam Memorial Golf Day. The event honours John’s son Alex, who passed away from bowel cancer in 2016. Chair of our Community Advisory Panel, Jeff Cuff, attended the event to speak about our research and the importance of community support. The golf day raised an incredible $9,800. 

Two men in bright neon yellow shirts and sun hats smiling next to their kayaks on a riverbank.

Jason Long

In November, Jason Long and Gordon Porter set off on the five day, 415km Massive Murray Paddle to raise vital funds for the BIL-PPP clinical trial for bile duct cancer. Through their efforts they raised over $11,300! 

A large team of runners wearing "No Guts No Glory" singlets posing together

Kms for Kaz

The ‘Kms for Kaz’ running team came together in loving memory of Karen (Kaz), a much-loved family member and friend, who sadly passed away from stomach cancer in 2023. They raised close to $5,000 in their Fernleigh 15 Newcastle run.

Two smiling women standing together with raffle prize baskets visible in the background.

Riversdale Golf Club

For the third consecutive year, the dedicated team at Riversdale Golf Club’s Women’s Charity Committee, held their golf event, raising $12,000 to support pancreatic cancer research. The event was attended by our Philanthropy Lead, Tiffany Meiliunas, who shared how funds raised by the community will help advance clinical trials and support people living with pancreatic cancer. The Riversdale team have raised an amazing $35,500 to date.

A wide aerial shot of a large group of golfers gathered on a green

Mike Leeke Foundation

Each December, the Mike Leeke Foundation host the Mike Leeke Classic Golf Day in memory of their good friend, Mike, who sadly passed away from bowel cancer in 2018. They raised $9,000 in 2025, doubling their donation from previous years, thanks to the support of their very generous community. 

Senior Event Manager at Mike Leeke Foundation, Gareth Norman says, “We all miss Mike and some of the memories we have will forever make us smile.”

Gutsy Challenge: Adventure with purpose

Gutsy Challenge treks are a wonderful way to connect with an incredible community of supporters, spend time in nature and raise much needed funds and awareness for GI cancer research. 

In 2025 we held two Gutsy Challenges: one in Kangaroo Island, and our annual trek in the Blue Mountains.

A group of travellers posing with a GI Cancer Institute banner in front of the Remarkable Rocks on Kangaroo Island.

Kangaroo Island, South Australia, 2025

11 Gutsy Challenge trekkers 

$54,000 raised

“It was an incredible experience with ten other legends I’m proud to now call friends. It was a very special way to honour the memory of my father-in-law while doing something practical to advance cancer research,” says first-time Gutsy trekker, Gabrielle Keen.

A group of hikers holding a GI Cancer Institute banner at a scenic lookout in the Blue Mountains.

Blue Mountains, New South Wales, 2025

22 Gutsy Challenge trekkers 

$47,000 raised including generous dollar matching from the Lachlan Kean Foundation

“I was proud to complete my second Gutsy Challenge. As a GI cancer survivor, I’m so grateful to have an opportunity to fundraise for vital research, meet lovely people, and get fitter at the same time,” says second time Gutsy trekker, Amanda Barry.

Six women smiling and holding orange cocktails on a boat with a scenic blue ocean and rocky cliffs in the background.

A gutsy tale of friendship

The Blue Mountains hold some of New South Wales’ most stunning views: majestic sandstone cliffs, endlessly stretching forests and some of the largest waterfalls in the region.

For Madeline Baker, Ksenija Bragg, Anna Draper, Victoria Janchek, Kathleen Quine and Tessa Sloane, the Blue Mountains also represent an opportunity for change.

Through the GI Cancer Trails’ Gutsy Challenge, they traversed 15km to raise funds for bowel cancer research in memory of their dear friend Lachlan Kean, who passed away in 2023 from bowel cancer.

“He spent the most difficult last months of his life selflessly determined to help raise necessary awareness around bowel cancer,” Kathleen says.

Honour roll

We are pleased to recognise the generosity and commitment of our donors who have generously supported GI cancer research in 2025.

$10,000+

Individual

  • William and Susan Andrews
  • Christine Bishop
  • John and Jan Burnett
  • Doug and Amanda Burnett
  • Nicola Coghill
  • Denise Dunphy
  • Eileen Gehling and Rob Gehling AO
  • Michelle Groves
  • Yvonne Horton
  • John Hull
  • Ann Waterford

Organisations/Foundations

  • Mostyn Family Foundation
  • Carlton Family Foundation
  • Randall Foundation
  • Alcheringa Farming Company Pty Ltd - Mt Burdett Foundation
  • Lachlan Kean Foundation

Estate

  • Late Isabelle Geraldine Redden
  • Estate of the Late Yvonne Kay-Sewell

$1,000 - $9,999

Individual

  • June Mary Sue Yek
  • Xander Gagnet
  • Benny Minor
  • Sam Sloane
  • Steve Caunt
  • Eric & Patricia Nagle
  • Nasir Khan
  • Helen Beattie
  • Kate Hobson
  • Danny Goulburn OAM and Family
  • Anne Maley In memory of Wes Maley
  • Peter Lemon
  • Anne Maley
  • Rowen Matthews
  • John and Dianne Ryall
  • Elisabeth Weise
  • Rowland Ball
  • Kenneth Barker
  • Helen Beattie
  • Barbara Beynon
  • Helen Binnie
  • Roslyn Brand
  • Jane Burchnall
  • Rozanne Butcher
  • M Cameron
  • Leith Cannons
  • Evelyn Chan
  • Jan Cicerello
  • Allyn Colgan
  • Joy Conner
  • Bhaskar and Chelana Desai
  • Tim Desilets
  • Sancha Dickson
  • Barbara Dungavell
  • K Emery
  • Allan Forbes
  • Eric Gayfer
  • Jan Gerrand
  • John Gestier
  • Clarence Gibbons
  • Maureen Gibson
  • Don Harris
  • Rodney Hawkins
  • Robert Hincks
  • Jennifer Hodge
  • Peter Howard
  • Dianne Imison
  • Greg Johnson
  • Richard Kearney
  • Alexander Kedzior
  • Andrew Kedzior
  • Judith Keech
  • Carole Kendall
  • Ross Kimber
  • Ann Korner
  • Heather Macfarlane
  • Bill Maher
  • Catherine Marshall
  • Barbara McGill
  • Douglas McGill
  • Peter McGrath
  • Margaret McIver
  • William and Marjorie McKenzie
  • Marie Miller
  • Margaret Milne
  • Valerie Newman
  • P, M and R Galea
  • Russell Peters
  • Ian Peters
  • Janet Pruden
  • B Rattray
  • Rodney Ridd
  • Gwenneth Roberts
  • Andrew Robertson
  • Belinda Roper
  • Patricia Scott
  • Paul Shea
  • Phillip and Ruth Shirriff
  • William Shorrock
  • Kaye Smith
  • Guy and Margaux Smith
  • Graham Stevens
  • J Sullivan
  • Martin Susans
  • Tracey Thornton
  • Henry Turnbull
  • Brian Ward
  • Graeme Watmuff
  • Sean Watson
  • Patricia Willard
  • David Williams
  • Kent Williams

Members

  • Rosemary Taylor

Organisations/Foundations

  • On Statenborough Retirement Village
  • Mike Leeke Foundation
  • BODYSYSTEM Physio

Pledged Bequests

  • Samantha Abad
  • Robert Cabion
  • Nella Calati
  • Mary Clift
  • Kerry Croydon
  • Chitra De Silva
  • Darcy Fechner
  • Neville Gallard
  • Clarence Gibbons
  • Joan Gibson
  • Ruth Henwood
  • Helen Illsley
  • Anne Jabara
  • Nichole Jager
  • Chriss Johnstone
  • Jennifer Jones
  • Isabel Kirsh
  • Gerlinde Kress
  • Nicky Lancaster
  • Peter Learmonth
  • Eileen Mason
  • Sarah McGoram
  • Helen McMahon
  • Janette Mutton
  • Gary Reid
  • Daine Robson
  • Marco Satti
  • Leonie Shearing
  • John Stokes
  • Elizabeth Thorp
  • Carole Tremblay
  • Paul Wedd
  • Andrew Wells
  • Jenny Wells
  • Susan Wong
  • Jonathan Wright

Community-funded research in 2025

The community helped to fund three studies this year:

  • The BIL-PPP study aims to evaluate the efficacy and tolerability of two drugs used together as ongoing treatment for patients with locally advanced or metastatic cholangiocarcinoma, after they have completed initial chemotherapy. It is open for patient enrolment in Victoria, New South Wales and South Australia.
  • The purpose of the PALEO study is to investigate whether a targeted combination of radiation, chemotherapy and immunotherapy can reduce side effects of dysphagia for oesophageal cancer patients.
  • PemOla aims to understand whether patients with metastatic pancreatic cancer will respond well to a combination of pembrolizumab and olaparib. This study opened in November 2025.